sgl tnfa_r1_pg_ml

Age

Visit number vs Tumor necrosis factor-alpha levels
N Mean StdDev Median Min Max Unknown Total
Baseline 317 5.4 ± 3.1 5.0 0.5 26.6 1 318
Follow-up 293 5.5 ± 2.8 5.1 0.7 24.2 8 301
Treatment Arm vs Tumor necrosis factor-alpha levels
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 317 5.4 ± 3.1 5.0 0.5 26.6 1 318
Healthy Lifestyles and Sleep Education - control arm (HLSE) 106 5.2 ± 2.8 4.7 1.5 16.5 - 106
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) 105 5.6 ± 3.6 4.9 1.3 26.6 1 106
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) 106 5.6 ± 3.0 5.2 0.5 23.3 - 106
Treatment Arm vs Tumor necrosis factor-alpha levels
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 293 5.5 ± 2.8 5.1 0.7 24.2 8 301
Healthy Lifestyles and Sleep Education - control arm (HLSE) 98 5.4 ± 3.0 5.1 1.2 18.4 2 100
Healthy Lifestyles and Sleep Education + (supplemental nocturnal) Oxygen - oxygen arm (HLSE-O) 98 5.5 ± 2.5 5.0 2.1 15.7 3 101
Healthy Lifestyles and Sleep Education + Positive airway pressure treatment - CPAP arm (HLSE-P) 97 5.4 ± 2.9 5.3 0.7 24.2 3 100
Age category vs Tumor necrosis factor-alpha levels
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 317 5.4 ± 3.1 5.0 0.5 26.6 1 318
45-54 years 53 5.1 ± 2.2 4.7 1.5 11.4 - 53
55-64 years 139 5.5 ± 3.5 5.0 0.5 26.6 - 139
65 years or older 125 5.5 ± 3.0 5.2 1.3 23.3 1 126
Age category vs Tumor necrosis factor-alpha levels
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 293 5.5 ± 2.8 5.1 0.7 24.2 7 300
45-54 years 46 5.4 ± 2.0 5.2 2.3 11.1 3 49
55-64 years 124 5.1 ± 2.3 4.9 0.7 13.5 3 127
65 years or older 123 5.9 ± 3.4 5.3 1.2 24.2 1 124
Gender of the participant vs Tumor necrosis factor-alpha levels
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 317 5.4 ± 3.1 5.0 0.5 26.6 1 318
Female 83 5.8 ± 3.5 5.2 1.3 23.3 1 84
Male 234 5.3 ± 3.0 4.9 0.5 26.6 - 234
Gender of the participant vs Tumor necrosis factor-alpha levels
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 293 5.5 ± 2.8 5.1 0.7 24.2 8 301
Female 77 6.0 ± 3.6 5.4 1.2 24.2 2 79
Male 216 5.3 ± 2.4 5.0 0.7 15.7 6 222
Race of the participant vs Tumor necrosis factor-alpha levels
Baseline
N Mean StdDev Median Min Max Unknown Total
Total 316 5.5 ± 3.1 5.0 0.5 26.6 1 317
White 256 5.7 ± 3.2 5.0 0.5 26.6 - 256
American Indian or Alaskan Native 2 3.6 ± 1.3 3.6 2.7 4.5 - 2
Black or African American 42 4.7 ± 2.7 4.4 1.4 13.6 1 43
Asian 6 4.0 ± 3.0 2.8 1.8 9.8 - 6
Native Hawaiian or other Pacific islander 1 1.5 - 1.5 1.5 1.5 - 1
Other 4 3.6 ± 2.6 2.6 1.8 7.3 - 4
Multiple 5 4.4 ± 1.5 4.8 1.7 5.5 - 5
Race of the participant vs Tumor necrosis factor-alpha levels
Follow-up
N Mean StdDev Median Min Max Unknown Total
Total 292 5.5 ± 2.8 5.1 0.7 24.2 7 299
White 236 5.6 ± 2.8 5.3 0.7 24.2 5 241
American Indian or Alaskan Native 2 5.2 ± 0.4 5.2 4.9 5.5 - 2
Black or African American 39 5.4 ± 3.3 4.6 1.2 18.4 2 41
Asian 6 3.4 ± 1.5 3.6 1.4 5.7 - 6
Native Hawaiian or other Pacific islander 1 2.4 - 2.4 2.4 2.4 - 1
Other 3 4.2 ± 3.1 3.9 1.2 7.3 - 3
Multiple 5 3.8 ± 1.3 4.5 2.3 5.0 - 5